These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9081364)

  • 1. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; Birkenhäger JC; van Leeuwen JP
    Eur J Cancer; 1996 May; 32A(5):842-8. PubMed ID: 9081364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells.
    Xie SP; James SY; Colston KW
    J Endocrinol; 1997 Sep; 154(3):495-504. PubMed ID: 9379127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation.
    Rozen F; Yang XF; Huynh H; Pollak M
    J Natl Cancer Inst; 1997 May; 89(9):652-6. PubMed ID: 9150190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.
    James SY; Mackay AG; Binderup L; Colston KW
    J Endocrinol; 1994 Jun; 141(3):555-63. PubMed ID: 8071654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
    Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.
    Colston KW; Mackay AG; James SY; Binderup L; Chander S; Coombes RC
    Biochem Pharmacol; 1992 Dec; 44(12):2273-80. PubMed ID: 1472092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.
    Simboli-Campbell M; Narvaez CJ; van Weelden K; Tenniswood M; Welsh J
    Breast Cancer Res Treat; 1997 Jan; 42(1):31-41. PubMed ID: 9116316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogens inhibit in vitro bone resorption stimulated by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogs EB1089 and KH1060.
    Vink-van Wijngaarden T; Birkenhäger JC; Kleinekoort WM; van den Bemd GJ; Pols HA; van Leeuwen JP
    Endocrinology; 1995 Feb; 136(2):812-5. PubMed ID: 7835315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells.
    James SY; Mackay AG; Colston KW
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):395-401. PubMed ID: 8903423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
    Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
    Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089.
    Huynh H; Pollak M; Zhang JC
    Int J Oncol; 1998 Jul; 13(1):137-43. PubMed ID: 9625815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
    Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
    Zhang X; Jiang F; Li P; Li C; Ma Q; Nicosia SV; Bai W
    Clin Cancer Res; 2005 Jan; 11(1):323-8. PubMed ID: 15671562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2.
    Akhter J; Lu Y; Finlay I; Pourgholami MH; Morris DL
    ANZ J Surg; 2001 Jul; 71(7):414-7. PubMed ID: 11450917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
    Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.
    Rozen F; Pollak M
    Int J Oncol; 1999 Sep; 15(3):589-94. PubMed ID: 10427145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells.
    Xie SP; Pirianov G; Colston KW
    Eur J Cancer; 1999 Nov; 35(12):1717-23. PubMed ID: 10674019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K; Flanagan L; Binderup L; Tenniswood M; Welsh J
    Endocrinology; 1998 Apr; 139(4):2102-10. PubMed ID: 9528999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
    Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
    Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.